PHF2P1: A Potential Drug Target and Biomarker for Disease (G266695)

Target Name: PHF2P1

NCBI ID: G266695

PHF2P1

Other Name(s): PHD finger protein 2 pseudogene 1 | DKFZp686A1627

PHF2P1: A Potential Drug Target and Biomarker for Disease

PHF2P1, also known as PHD finger protein 2 pseudogene 1, is a gene that encodes a protein known as PHD finger protein 2. PHD finger proteins are a family of transmembrane proteins that are characterized by the presence of a short alpha-helices and a long terminal extension, known as a pseudogene, which is a gene that has been expressed in the cell but does not code for a functional protein.

PHF2P1 was first identified in the late 1990s as a gene that was highly expressed in the human liver, and it has since been shown to be involved in a number of important cellular processes, including metabolism, cell signaling, and inflammation. In particular, PHF2P1 has been shown to be involved in the regulation of cellular metabolism, as well as in the development and progression of a number of diseases, including cancer.

One of the key features of PHF2P1 is its ability to interact with a variety of different proteins, including tyrosine hydroxylase (TH), a enzyme that is involved in the metabolism of a wide range of compounds, including drugs. This interaction between PHF2P1 and TH has led to the hypothesis that PHF2P1 may be a drug target, and that it may be able to serve as a biomarker for the diagnosis and treatment of a variety of diseases.

In addition to its potential as a drug target, PHF2P1 has also been shown to be involved in a number of other cellular processes that are important for human health. For example, it has been shown to be involved in the regulation of cell adhesion, as well as in the development and progression of a number of diseases, including cancer.

Another promising aspect of PHF2P1 is its ability to be targeted by small molecules, such as drugs, RNA interference (RNAi) agents, and CRISPR/Cas9 systems. This has led to the development of a number of compounds that have been shown to be effective in inhibiting the activity of PHF2P1, and has suggested that PHF2P1 may be an attractive target for the development of new pharmaceuticals for a variety of diseases.

In conclusion, PHF2P1 is a gene that has been shown to be involved in a number of important cellular processes, including metabolism, cell signaling, and inflammation. Its ability to interact with a variety of different proteins, including tyrosine hydroxylase, has led to the hypothesis that it may be a drug target, and that it may be able to serve as a biomarker for the diagnosis and treatment of a variety of diseases. Further research is needed to fully understand the role of PHF2P1 in human health and to develop new treatments based on its potential as a drug target.

Protein Name: PHD Finger Protein 2 Pseudogene 1

The "PHF2P1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about PHF2P1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets